Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial.

MLA

Pokharel, Sunil, et al. “Co-Trimoxazole versus Azithromycin for the Treatment of Undifferentiated Febrile Illness in Nepal: Study Protocol for a Randomized Controlled Trial.” Trials, vol. 18, Oct. 2017, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13063-017-2199-6.

APA

Pokharel, S., Basnyat, B., Arjyal, A., Pathak Mahat, S., Raj Kumar, K. C., Bhuju, A., Poudyal, B., Kestelyn, E., Shrestha, R., Dung Nguyen Thi Phuong, Thapa, R., Karki, M., Dongol, S., Karkey, A., Wolbers, M., Baker, S., Thwaites, G., Mahat, S. P., Kc, R. K., & Phuong, D. N. T. (2017). Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. Trials, 18, 1–13. https://doi.org/10.1186/s13063-017-2199-6

Chicago

Pokharel, Sunil, Buddha Basnyat, Amit Arjyal, Saruna Pathak Mahat, K. C. Raj Kumar, Abhusani Bhuju, Buddhi Poudyal, et al. 2017. “Co-Trimoxazole versus Azithromycin for the Treatment of Undifferentiated Febrile Illness in Nepal: Study Protocol for a Randomized Controlled Trial.” Trials 18 (October): 1–13. doi:10.1186/s13063-017-2199-6.